Home/NOVITÀ/TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders NOVITÀPress ReleasesTIF News (IT) TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Less than a minute 211020_ TIF Announcement_COVID-19 Vaccine Boosters Tags#news AtRisk COVID-19 COVID-19 Pandemic COVID-19 Vaccines Haemoglobin Disorders Healthcare Professionals Patients Sickle cell Thalassaemia TIF News Vaccinations Vulnerable Less than a minute Facebook Twitter LinkedIn Share via Email Print
